Genomics England has today announced that it has contracted with WuXi NextCODE as a Clinical Interpretation Partner for the 100,000 Genomes Project. The China, US and Iceland-based company is the first to work with them on cancer samples and will also interpret samples in rare disease. Genomics England will work with the clinical interpretation partners […]
COLUMBUS, Ohio – GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that it’s genomic analysis pipeline delivered the bioinformatics and genomic sequence analysis capability supporting Nationwide Children’s efforts to win the CLARITY Undiagnosed Challenge. An estimated 25-30 million Americans suffer from a rare disorder in the United States alone, according […]
CINCINNATI — Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announced that it has made a minority investment in Oasis Diagnostics® Corporation (“Oasis”), with the right to acquire Oasis in the future. The terms of the transaction were not disclosed. Oasis designs, develops, manufactures and sells pre-analytic tools for the collection, preservation, and transportation of saliva/oral […]
MIAMI — Beckman Coulter Life Sciences and IncellDx, Inc. announced today they have signed a distribution agreement which focuses exclusively on clinical researchers in China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer. The commercial partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering […]
LUXEMBOURG — Advanced Biological Laboratories (ABL) announced the launch of the DeepChek® SingleRound HIV and Hepatitis C Virus (HCV) Genotyping and Sequencing assays. These two assays are the first in its virology reagents portfolio. The DeepChek® SingleRound assays are currently available for Research Use Only. The DeepChek® SingleRound HIV RT-PCR and Sequencing Assay detects all […]
Santa Clara, Calif. — Affymetrix, Inc. (NASDAQ: AFFX) and XRGenomics LTD, a UK-based biotechnology company, announced today that they will collaborate on research and development of a new generation of diagnostic tests for age-related diseases. Over 50 percent of healthcare costs are spent on those aged 65 and older and according to the G8 Summit […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of its 3D BiologyTM portfolio with the commercial launch of the nCounter® PanCancer Profiles, seven new gene expression panels each designed to interrogate a focused area of cancer biology including immuno-oncology. The […]
Austin, Texas, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the start of commercialization activities for its GeneReader NGS System, the first complete Sample to Insight next-generation sequencing (NGS) solution designed for any laboratory to deliver actionable results. With the introduction of the GeneReader NGS System*, QIAGEN is offering […]
ALAMEDA, Calif. & AUSTIN, Tex. – LifeMap Sciences, Inc. (“LifeMap”), a subsidiary of BioTime, Inc., and Lab7 Systems, Inc., announced today a partnership and launch of an integrated solution in the next-generation genomic sequencing (NGS) field, a multi-billion dollar, rapidly growing global market. LifeMap’s VarElect, The NGS Phenotyper, is now integrated into the Lab7 Enterprise […]
SAN ANTONIO; SHANGHAI; CAMBRIDGE, Mass.; REYKJAVIK; and MADRID, November 3, 2015 – The San Antonio 1000 Cancer Genomes Project (SA1kCGP), WuXi NextCODE, and South Texas Accelerated Research Therapeutics (START) today announced a partnership that will enable San Antonio’s pioneering city-wide cancer genomics effort to contribute directly to improving the clinical treatment of cancer around the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
